Details for Patent: 9,974,790
✉ Email this page to a colleague
Which drugs does patent 9,974,790 protect, and when does it expire?
Patent 9,974,790 protects OPZELURA and is included in one NDA.
Protection for OPZELURA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has one hundred and fifty-three patent family members in thirty-five countries.
Summary for Patent: 9,974,790
Title: | Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors |
Abstract: | The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. |
Inventor(s): | Rodgers; James D. (Landenberg, PA), Shepard; Stacey (Wilmington, DE) |
Assignee: | Incyte Corporation (Wilmington, DE) Incyte Holdings Corporation (Wilmington, DE) |
Application Number: | 15/356,957 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 9,974,790
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Incyte Corp | OPZELURA | ruxolitinib phosphate | CREAM;TOPICAL | 215309-001 | Sep 21, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,974,790
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 057995 | ⤷ Try a Trial | |||
Austria | E525374 | ⤷ Try a Trial | |||
Australia | 2006326548 | ⤷ Try a Trial | |||
Brazil | PI0619817 | ⤷ Try a Trial | |||
Canada | 2632466 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |